Skip to main content
Clinical Trials/NCT04132414
NCT04132414
Withdrawn
Not Applicable

Monitoring Of REgional Cerebral Oxygenation (rcSO2 ) With Near INFrared SpectrOscopy (NIRS) During Non-cardiac Surgery in Preterms, Neonates and Infants in Addition to Standard Monitoring to Guide Intraoperative Management

Medical University of Graz0 sites40 target enrollmentDecember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Oxygenation
Sponsor
Medical University of Graz
Enrollment
40
Primary Endpoint
Cerebral hypoxic burden
Status
Withdrawn
Last Updated
7 months ago

Overview

Brief Summary

The brain is a very vulnerable organ, especially in premature babies, newborns and infants. However, during anesthesia, the oxygenation of the brain can only be monitored indirectly and insufficiently. Near-infrared spectroscopy (NIRS) is an established monitoring method in other areas (e.g., neonatology, cardiac anesthesia), which provides non-invasive information about the regional oxygen supply of the brain. The integration of this monitoring device into the anaesthesiological care for neonates and infants could reduce the risk of cerebral hypoxia. The planned study investigates whether the use of NIRS in anesthetized children up to 6 months can prevent or influence the occurrence of cerebral hypoxia.

Registry
clinicaltrials.gov
Start Date
December 1, 2022
End Date
December 1, 2023
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Medical University of Graz
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Expected duration of Anesthesia \>45 minutes
  • Intervention/surgery in the operating room

Exclusion Criteria

  • Impossibility to place cerebral NIRS sensor
  • Known cerebral pathology
  • Missing parental consent
  • Congenial cardiac condition with right to left shunt
  • Cardiac surgery

Outcomes

Primary Outcomes

Cerebral hypoxic burden

Time Frame: 1 day

Time under 65% cerebral oxygen saturation

Secondary Outcomes

  • Fluid administration(1 day)
  • Number of participants with Vasopressor or Inotrope administered(1 day)
  • Number of participants with erythrocyte administration(1 day)
  • Fraction of inspired oxygen(1 day)

Similar Trials